These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2852597)

  • 1. Selective agents for muscarinic receptors linked to phosphoinositide breakdown.
    Noronha-Blob L; Canning B; Costello D; Kinnier WJ
    Eur J Pharmacol; 1988 Sep; 154(2):161-7. PubMed ID: 2852597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of muscarinic receptors coupled to phosphoinositide breakdown in guinea pig brain and peripheral tissues.
    Noronha-Blob L; Lowe VC; Hanson RC; U'Prichard DC
    Life Sci; 1987 Aug; 41(8):967-75. PubMed ID: 3039279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of muscarinic acetylcholine receptors coupled to phosphatidylinositol turnover and to adenylate cyclase in guinea-pig atria and ventricles.
    Woodcock EA; Leung E; Mcleod JK
    Eur J Pharmacol; 1987 Jan; 133(3):283-9. PubMed ID: 3556393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.
    Hagan JJ; van der Heijden B; Broekkamp CL
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):476-83. PubMed ID: 3244389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2,5-Thiadiazole derivatives of arecoline stimulate M1 receptors coupled to phosphoinositide turnover.
    Periyasamy S; Messer WS; Roknich S; Sauerberg P; Hoss W
    Brain Res; 1995 Sep; 693(1-2):118-23. PubMed ID: 8653399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic M2 receptors coupled to inhibition of adenylate cyclase in rat heart.
    Wei JW; Wang MC
    Chin J Physiol; 1990; 33(4):315-27. PubMed ID: 2129026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition.
    Baumgold J; White T
    Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
    Monsma FJ; Abood LG; Hoss W
    Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of methoctramine in blocking muscarinic receptors which inhibit adenylate cyclase in cerebellar granule cells.
    McLeskey SW; Fischofer-Hahn C; Takahashi K; Wojcik WJ
    Neuropharmacology; 1990 Sep; 29(9):853-60. PubMed ID: 2293064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic suppression of the evoked N-wave by oxotremorine-M recorded in the guinea-pig olfactory cortex slice.
    Bagetta G; Constanti A
    Eur J Pharmacol; 1990 Mar; 178(1):91-6. PubMed ID: 2332031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices.
    Lapchak PA; Araujo DM; Quirion R; Collier B
    Brain Res; 1989 Sep; 496(1-2):285-94. PubMed ID: 2804636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes.
    Eglen RM; Whiting RL
    Br J Pharmacol; 1987 Apr; 90(4):701-7. PubMed ID: 3580704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M3 muscarinic cholinoceptors are linked to phosphoinositide metabolism in rat cerebellar granule cells.
    Whitham EM; Challiss RA; Nahorski SR
    Eur J Pharmacol; 1991 Mar; 206(3):181-9. PubMed ID: 1649760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity.
    Olianas MC; Onali P
    J Pharmacol Exp Ther; 1991 Nov; 259(2):673-9. PubMed ID: 1941616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
    Thomas EA; Baker SA; Ehlert FJ
    Mol Pharmacol; 1993 Jul; 44(1):102-10. PubMed ID: 8393516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.